Second Sight Medical Products- Warrants (14/03/2024) Common Stock

As of the most recent data (June 2026), EYESW shows a common stock of $9K. That compares with $6K in the prior-year period — up 50.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, EYESW's common stock is now $9K (was $6K) — a 50.0% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Second Sight Medical Products- Warrants (14/03/2024) is outperforming or lagging.

Tracking EYESW's common stock over time shows whether Second Sight Medical Products- Warrants (14/03/2024) is scaling, shrinking, or reshaping that part of the business. The current reading is $9K That compares with $6K in the prior-year period — up 50.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this common stock page, Stockcircle has Second Sight Medical Products- Warrants (14/03/2024)'s full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect common stock (currently $9K) with ownership activity and broader fundamentals.

Second Sight Medical Products- Warrants (14/03/2024)'s common stock is $9K; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.